TXLNG improves insulin resistance in obese subjects in vitro and in vivo by inhibiting ATF4 transcriptional activity.
Tao J, Gu P, Lai H, Peng H, Guo Z, Yuan Y, Yu X, Shen X, Liu J, Xier Z, et al. Mol Cell Endocrinol. 2023 Jun 1; 568-569:111928. Epub 2023 Apr 5.